6 Results for "

ICI 204219

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "ICI 204219" in MCE Product Catalog:

4
4 Cited Publications
Cat. No.: HY-17492
CAS No.: 107753-78-6
Synonyms: ICI 204219
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology Cancer

Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects.
loading...
    loading...
Cat. No.: HY-17492R
CAS No.: 107753-78-6
Synonyms: ICI 204219 (Standard)
Zafirlukast (Standard) is the analytical standard of Zafirlukast. This product is intended for research and analytical applications. Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects.
loading...
    loading...
Cat. No.: HY-17492S3
CAS No.: 1109278-84-3
Synonyms: ICI 204219-d6
Zafirlukast-d6 is deuterated labeled Zafirlukast (HY-17492). Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects.
loading...
    loading...
Cat. No.: HY-17492S1
CAS No.: 2140305-18-4
Synonyms: ICI 204219-13C,d3
Zafirlukast- 13C,d3 is the 13C- and deuterium labeled Zafirlukast. Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects.
loading...
    loading...
Cat. No.: HY-17492S2
Synonyms: ICI 204219-13C,d6
Zafirlukast- 13C,d6 is the 13C- and deuterium labeled Zafirlukast. Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects.
loading...
    loading...
Cat. No.: HY-17492S
CAS No.: 1217174-18-9
Zafirlukast-d7 is the deuterium labeled Zafirlukast. Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects .
loading...
    loading...